-
Jul 16, 2026, 10:36 am141 ptsTrendingTop
Ganjapreneur
A THC and CBD formulation significantly reduced agitation among patients with late-stage dementia in a first-of-its-kind clinical trial, MedicalXpress reports. The multicenter, randomized, double-blind, placebo-controlled Phase II study (known as the LiBBY trial, for Life’s End Benefits of Cannabidiol and…
NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.
Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.
Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.
